Trial
NCT02255227
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Pfizer
Condition
Infections, Pneumococcal
Intervention
Prevenar 13
Why stopped
low inclusion rates
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-15